EARLY DATA FROM A PHASE I STUDY OF NINTEDANIB (BIBF 1120) IN ASIAN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Yen, C. [1 ]
Shen, Y. [2 ]
Shiah, H. [3 ]
Chen, J. [2 ]
Hsu, C. [2 ]
Hsu, C. [2 ]
Huang, D. C. [4 ]
Hocke, J. [5 ]
Su, W. [1 ]
Cheng, A. [2 ]
机构：
[1] Natl Cheng Kung Univ, Coll Med & Hosp, Tainan 70101, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Hlth Res Inst, Tainan, Taiwan
[4] Boehringer Ingelheim Taiwan Ltd, Oncol, Taipei, Taiwan
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Oncol, Biberach, Germany
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [1] PHASE I STUDY OF NINTEDANIB (BIBF 1120) IN EUROPEAN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Palmer, D.
    Loembe, A. B.
    Studeny, M.
    Hocke, J.
    Meyer, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 245 - 245
  • [2] Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
    Mross, Klaus
    Stefanic, Martin
    Gmehling, Daniela
    Frost, Annette
    Baas, Franziska
    Unger, Clemens
    Strecker, Ralph
    Henning, Juergen
    Gaschler-Markefski, Birgit
    Stopfer, Peter
    de Rossi, Lothar
    Kaiser, Rolf
    CLINICAL CANCER RESEARCH, 2010, 16 (01) : 311 - 319
  • [3] Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity
    Tai, Wei-Tien
    Shiau, Chung-Wai
    Li, Yong-Shi
    Chang, Chun-Wei
    Huang, Jui-Wen
    Hsueh, Ting-Ting
    Chen, Kuen-Feng
    CANCER RESEARCH, 2014, 74 (19)
  • [4] Nintedanib (BIBF-1120) inhibits hepatocellular carcinoma growth independent of angiokinase activity
    Tai, Wei-Tien
    Shiau, Chung-Wai
    Li, Yong-Shi
    Chang, Chun-Wei
    Huang, Jui-Wen
    Hsueh, Ting-Ting
    Yu, Hui-Chuan
    Chen, Kuen-Feng
    JOURNAL OF HEPATOLOGY, 2014, 61 (01) : 89 - 97
  • [5] Phase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment
    Okusaka, Takuji
    Otsuka, Taiga
    Ueno, Hideki
    Mitsunaga, Shuichi
    Sugimoto, Rie
    Muro, Kei
    Saito, Isao
    Tadayasu, Yusuke
    Inoue, Kohei
    Loembe, Arsene-Bienvenu
    Ikeda, Masafumi
    CANCER SCIENCE, 2016, 107 (12) : 1791 - 1799
  • [6] A phase I dose-escalation study of volasertib (BI 6727) combined with nintedanib (BIBF 1120) in advanced solid tumors
    De Braud, Filippo G.
    Cascinu, Stefano
    Spitaleri, Gianluca
    Pilz, Korinna
    Clementi, Laura
    Liu, Dan
    Glomb, Patricia
    De Pas, Tommaso
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma
    Yen, Chia-Jui
    Kim, Tae-You
    Feng, Yin-Hsun
    Chao, Yee
    Lin, Deng-Yn
    Ryoo, Baek-Yeol
    Huang, Dennis Chin-Lun
    Schnell, David
    Hocke, Julia
    Loembe, Arsene-Bienvenu
    Cheng, Ann-Lii
    LIVER CANCER, 2018, 7 (02) : 165 - 178
  • [8] Safety and efficacy of nintedanib (BIBF 1120) plus pemetrexed in Japanese patients with advanced or recurrent non-small cell lung cancer (NSCLC): A phase I study
    Daga, Haruko
    Takeda, Koji
    Okada, Hideaki
    Miyazaki, Masaki
    Ueda, Shinya
    Kaneda, Hiroyasu
    Okamoto, Isamu
    Yoh, Kiyotaka
    Goto, Koichi
    Konishi, Koichi
    Sarashina, Akiko
    Yagi, Nobutaka
    Mera, Kiyomi
    Kaiser, Rolf
    Nakagawa, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] PHASE I STUDY OF AFATINIB (BIBW 2992), AN ERBB FAMILY BLOCKER PLUS NINTEDANIB (BIBF 1120), A TRIPLE ANGIOKINASE INHIBITOR, IN PATIENTS (PTS) WITH ADVANCED SOLID TUMOURS
    Soria, J.
    Hollebecque, A.
    Massard, C.
    Deutsch, E.
    Varga, A.
    Morsli, N.
    Kaci, M. Ould
    Staines, H.
    Marzin, K.
    Bahleda, R.
    ANNALS OF ONCOLOGY, 2012, 23 : 155 - 155
  • [10] GYN 4: phase I study of BIBF 1120 in combination with paclitaxel/carboplatin in patients with advanced gynecological malignancies
    Huober, J.
    Pfisterer, J.
    Wimberger, P.
    Loibl, S.
    Stopfer, P.
    du Bois, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S11 - S11
12345